Get the app
Peter Forsberg
Works at the Colorado Blood Cancer Institute in Denver, US. Explores the evolving understanding and management of neurotoxicity associated with CAR T-cell therapy in MM.
Best podcasts with Peter Forsberg
Ranked by the Snipd community
Aug 26, 2025
• 9min
How can neurotoxicity associated with CAR T-cell therapy in MM be managed?
chevron_right
In this engaging discussion, Dr. Peter Forsberg from the Colorado Blood Cancer Institute sheds light on the complexities of neurotoxicity related to CAR T-cell therapy in multiple myeloma. He discusses the critical need for early identification of symptoms and innovative management strategies, particularly focusing on immune effector cell-associated neurotoxicity syndrome (ICANS). Forsberg underscores how collaboration among healthcare professionals can refine diagnostic criteria and improve patient care as CAR T-cell therapies evolve.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
